G2-WELL COMMUNITY INTEREST COMPANY

Company Registration Number:
SC543102 (Scotland)

Unaudited statutory accounts for the year ended 31 August 2024

Period of accounts

Start date: 1 September 2023

End date: 31 August 2024

G2-WELL COMMUNITY INTEREST COMPANY

Contents of the Financial Statements

for the Period Ended 31 August 2024

Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

G2-WELL COMMUNITY INTEREST COMPANY

Profit And Loss Account

for the Period Ended 31 August 2024

2024 2023


£

£
Turnover: 11,285 15,670
Cost of sales: ( 5,509 ) ( 5,680 )
Gross profit(or loss): 5,776 9,990
Administrative expenses: ( 33,596 ) ( 7,910 )
Other operating income: 24,293
Operating profit(or loss): (3,527) 2,080
Interest payable and similar charges: ( 493 ) ( 665 )
Profit(or loss) before tax: (4,020) 1,415
Profit(or loss) for the financial year: (4,020) 1,415

G2-WELL COMMUNITY INTEREST COMPANY

Balance sheet

As at 31 August 2024

Notes 2024 2023


£

£
Current assets
Debtors: 3 761 1,530
Cash at bank and in hand: 4,722 900
Total current assets: 5,483 2,430
Net current assets (liabilities): 5,483 2,430
Total assets less current liabilities: 5,483 2,430
Creditors: amounts falling due after more than one year: 4 ( 9,692 ) ( 2,619 )
Total net assets (liabilities): (4,209) (189)
Capital and reserves
Called up share capital: 100 100
Profit and loss account: (4,309 ) (289 )
Total Shareholders' funds: ( 4,209 ) (189)

The notes form part of these financial statements

G2-WELL COMMUNITY INTEREST COMPANY

Balance sheet statements

For the year ending 31 August 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 28 April 2025
and signed on behalf of the board by:

Name: Ludovic Roy
Status: Director

The notes form part of these financial statements

G2-WELL COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 August 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

G2-WELL COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 August 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 0 0

G2-WELL COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 August 2024

3. Debtors

2024 2023
£ £
Other debtors 761 1,530
Total 761 1,530

G2-WELL COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 August 2024

4. Creditors: amounts falling due after more than one year note

2024 2023
£ £
Other creditors 9,692 2,619
Total 9,692 2,619

COMMUNITY INTEREST ANNUAL REPORT

G2-WELL COMMUNITY INTEREST COMPANY

Company Number: SC543102 (Scotland)

Year Ending: 31 August 2024

Company activities and impact

We have set out on a journey to support cancer care, our focus is on providing empowering, targeted rehabilitation support to individuals facing colorectal, breast, and prostate cancer. Central to our mission is nurturing and uplifting the wellbeing of patients within the NHS and Beatson Cancer Charity community, we have supported over 100 people within our first year. With a proactive approach before, during, and after treatment, we guide patients towards smoother post-treatment recovery, easing the weight of care in the community. Through our compassionate efforts, we aim to improve treatment resilience, lessen healthcare demands, and sow the seeds for a brighter, healthier tomorrow for all those touched by cancer.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
28 April 2025

And signed on behalf of the board by:
Name: Ludovic Roy
Status: Director